 | • レポートコード：MRC2Q12-16756 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、細胞毒性検査の世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に細胞毒性検査のグローバル市場のxxx％を占める「溶出検査法」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「医療機器」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 細胞毒性検査の中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの細胞毒性検査市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 細胞毒性検査のグローバル主要プレイヤーには、Sartorius、UL、Eurofins、SGS、Emery Pharma、Nelson Labs、UFAG Laboratorien AG、Pacific BioLabs、NorthEast BioLab、Biosafe Ltd、Creative Bioarray、Evercyte、IONTOX、Applied StemCell、Xenometrix AG、TÜV SÜD、Medicilon、Huatongweiなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 細胞毒性検査市場は、種類と用途によって区分されます。世界の細胞毒性検査市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 溶出検査法、寒天オーバーレイ法、ダイレクトコンタクト法、MTTアッセイ法、その他 【用途別セグメント】 医療機器、医療用付属品、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 細胞毒性検査製品概要 - 種類別市場（溶出検査法、寒天オーバーレイ法、ダイレクトコンタクト法、MTTアッセイ法、その他） - 用途別市場（医療機器、医療用付属品、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の細胞毒性検査販売量予測2017-2028 - 世界の細胞毒性検査売上予測2017-2028 - 細胞毒性検査の地域別販売量 - 細胞毒性検査の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別細胞毒性検査販売量 - 主要メーカー別細胞毒性検査売上 - 主要メーカー別細胞毒性検査価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（溶出検査法、寒天オーバーレイ法、ダイレクトコンタクト法、MTTアッセイ法、その他） - 細胞毒性検査の種類別販売量 - 細胞毒性検査の種類別売上 - 細胞毒性検査の種類別価格 ・用途別市場規模（医療機器、医療用付属品、その他） - 細胞毒性検査の用途別販売量 - 細胞毒性検査の用途別売上 - 細胞毒性検査の用途別価格 ・北米市場 - 北米の細胞毒性検査市場規模（種類別、用途別） - 主要国別の細胞毒性検査市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの細胞毒性検査市場規模（種類別、用途別） - 主要国別の細胞毒性検査市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の細胞毒性検査市場規模（種類別、用途別） - 主要国別の細胞毒性検査市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の細胞毒性検査市場規模（種類別、用途別） - 主要国別の細胞毒性検査市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの細胞毒性検査市場規模（種類別、用途別） - 主要国別の細胞毒性検査市場規模（トルコ、サウジアラビア） ・企業情報 Sartorius、UL、Eurofins、SGS、Emery Pharma、Nelson Labs、UFAG Laboratorien AG、Pacific BioLabs、NorthEast BioLab、Biosafe Ltd、Creative Bioarray、Evercyte、IONTOX、Applied StemCell、Xenometrix AG、TÜV SÜD、Medicilon、Huatongwei ・産業チェーン及び販売チャネル分析 - 細胞毒性検査の産業チェーン分析 - 細胞毒性検査の原材料 - 細胞毒性検査の生産プロセス - 細胞毒性検査の販売及びマーケティング - 細胞毒性検査の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 細胞毒性検査の産業動向 - 細胞毒性検査のマーケットドライバー - 細胞毒性検査の課題 - 細胞毒性検査の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Cytotoxicity Testing estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Cytotoxicity Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Cytotoxicity Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Cytotoxicity Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Cytotoxicity Testing include Sartorius, UL, Eurofins, SGS, Emery Pharma, Nelson Labs, UFAG Laboratorien AG, Pacific BioLabs and NorthEast BioLab, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Cytotoxicity Testing companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Cytotoxicity Testing market. Further, it explains the major drivers and regional dynamics of the global Cytotoxicity Testing market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Sartorius
UL
Eurofins
SGS
Emery Pharma
Nelson Labs
UFAG Laboratorien AG
Pacific BioLabs
NorthEast BioLab
Biosafe Ltd
Creative Bioarray
Evercyte
IONTOX
Applied StemCell
Xenometrix AG
TÜV SÜD
Medicilon
Huatongwei
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Cytotoxicity Testing Segment by Type
Elution Testing Method
Agar Overlay Method
Direct Contact Method
MTT Assay Method
Others
Cytotoxicity Testing Segment by Application
Medical Device
Medical Accessories
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Cytotoxicity Testing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Cytotoxicity Testing market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Cytotoxicity Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cytotoxicity Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cytotoxicity Testing revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Cytotoxicity Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Cytotoxicity Testing revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sartorius, UL, Eurofins, SGS, Emery Pharma, Nelson Labs, UFAG Laboratorien AG, Pacific BioLabs and NorthEast BioLab, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cytotoxicity Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cytotoxicity Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cytotoxicity Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cytotoxicity Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Elution Testing Method
1.2.3 Agar Overlay Method
1.2.4 Direct Contact Method
1.2.5 MTT Assay Method
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cytotoxicity Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Medical Device
1.3.3 Medical Accessories
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cytotoxicity Testing Market Perspective (2017-2028)
2.2 Cytotoxicity Testing Growth Trends by Region
2.2.1 Cytotoxicity Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cytotoxicity Testing Historic Market Size by Region (2017-2022)
2.2.3 Cytotoxicity Testing Forecasted Market Size by Region (2023-2028)
2.3 Cytotoxicity Testing Market Dynamics
2.3.1 Cytotoxicity Testing Industry Trends
2.3.2 Cytotoxicity Testing Market Drivers
2.3.3 Cytotoxicity Testing Market Challenges
2.3.4 Cytotoxicity Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cytotoxicity Testing Players by Revenue
3.1.1 Global Top Cytotoxicity Testing Players by Revenue (2017-2022)
3.1.2 Global Cytotoxicity Testing Revenue Market Share by Players (2017-2022)
3.2 Global Cytotoxicity Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cytotoxicity Testing Revenue
3.4 Global Cytotoxicity Testing Market Concentration Ratio
3.4.1 Global Cytotoxicity Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cytotoxicity Testing Revenue in 2021
3.5 Cytotoxicity Testing Key Players Head office and Area Served
3.6 Key Players Cytotoxicity Testing Product Solution and Service
3.7 Date of Enter into Cytotoxicity Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cytotoxicity Testing Breakdown Data by Type
4.1 Global Cytotoxicity Testing Historic Market Size by Type (2017-2022)
4.2 Global Cytotoxicity Testing Forecasted Market Size by Type (2023-2028)
5 Cytotoxicity Testing Breakdown Data by Application
5.1 Global Cytotoxicity Testing Historic Market Size by Application (2017-2022)
5.2 Global Cytotoxicity Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cytotoxicity Testing Market Size (2017-2028)
6.2 North America Cytotoxicity Testing Market Size by Type
6.2.1 North America Cytotoxicity Testing Market Size by Type (2017-2022)
6.2.2 North America Cytotoxicity Testing Market Size by Type (2023-2028)
6.2.3 North America Cytotoxicity Testing Market Share by Type (2017-2028)
6.3 North America Cytotoxicity Testing Market Size by Application
6.3.1 North America Cytotoxicity Testing Market Size by Application (2017-2022)
6.3.2 North America Cytotoxicity Testing Market Size by Application (2023-2028)
6.3.3 North America Cytotoxicity Testing Market Share by Application (2017-2028)
6.4 North America Cytotoxicity Testing Market Size by Country
6.4.1 North America Cytotoxicity Testing Market Size by Country (2017-2022)
6.4.2 North America Cytotoxicity Testing Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cytotoxicity Testing Market Size (2017-2028)
7.2 Europe Cytotoxicity Testing Market Size by Type
7.2.1 Europe Cytotoxicity Testing Market Size by Type (2017-2022)
7.2.2 Europe Cytotoxicity Testing Market Size by Type (2023-2028)
7.2.3 Europe Cytotoxicity Testing Market Share by Type (2017-2028)
7.3 Europe Cytotoxicity Testing Market Size by Application
7.3.1 Europe Cytotoxicity Testing Market Size by Application (2017-2022)
7.3.2 Europe Cytotoxicity Testing Market Size by Application (2023-2028)
7.3.3 Europe Cytotoxicity Testing Market Share by Application (2017-2028)
7.4 Europe Cytotoxicity Testing Market Size by Country
7.4.1 Europe Cytotoxicity Testing Market Size by Country (2017-2022)
7.4.2 Europe Cytotoxicity Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cytotoxicity Testing Market Size (2017-2028)
8.2 Asia-Pacific Cytotoxicity Testing Market Size by Type
8.2.1 Asia-Pacific Cytotoxicity Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cytotoxicity Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cytotoxicity Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific Cytotoxicity Testing Market Size by Application
8.3.1 Asia-Pacific Cytotoxicity Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cytotoxicity Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cytotoxicity Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Cytotoxicity Testing Market Size by Region
8.4.1 Asia-Pacific Cytotoxicity Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cytotoxicity Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cytotoxicity Testing Market Size (2017-2028)
9.2 Latin America Cytotoxicity Testing Market Size by Type
9.2.1 Latin America Cytotoxicity Testing Market Size by Type (2017-2022)
9.2.2 Latin America Cytotoxicity Testing Market Size by Type (2023-2028)
9.2.3 Latin America Cytotoxicity Testing Market Share by Type (2017-2028)
9.3 Latin America Cytotoxicity Testing Market Size by Application
9.3.1 Latin America Cytotoxicity Testing Market Size by Application (2017-2022)
9.3.2 Latin America Cytotoxicity Testing Market Size by Application (2023-2028)
9.3.3 Latin America Cytotoxicity Testing Market Share by Application (2017-2028)
9.4 Latin America Cytotoxicity Testing Market Size by Country
9.4.1 Latin America Cytotoxicity Testing Market Size by Country (2017-2022)
9.4.2 Latin America Cytotoxicity Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cytotoxicity Testing Market Size (2017-2028)
10.2 Middle East & Africa Cytotoxicity Testing Market Size by Type
10.2.1 Middle East & Africa Cytotoxicity Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cytotoxicity Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cytotoxicity Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa Cytotoxicity Testing Market Size by Application
10.3.1 Middle East & Africa Cytotoxicity Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cytotoxicity Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cytotoxicity Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Cytotoxicity Testing Market Size by Country
10.4.1 Middle East & Africa Cytotoxicity Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cytotoxicity Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sartorius
11.1.1 Sartorius Company Details
11.1.2 Sartorius Business Overview
11.1.3 Sartorius Cytotoxicity Testing Introduction
11.1.4 Sartorius Revenue in Cytotoxicity Testing Business (2017-2022)
11.1.5 Sartorius Recent Developments
11.2 UL
11.2.1 UL Company Details
11.2.2 UL Business Overview
11.2.3 UL Cytotoxicity Testing Introduction
11.2.4 UL Revenue in Cytotoxicity Testing Business (2017-2022)
11.2.5 UL Recent Developments
11.3 Eurofins
11.3.1 Eurofins Company Details
11.3.2 Eurofins Business Overview
11.3.3 Eurofins Cytotoxicity Testing Introduction
11.3.4 Eurofins Revenue in Cytotoxicity Testing Business (2017-2022)
11.3.5 Eurofins Recent Developments
11.4 SGS
11.4.1 SGS Company Details
11.4.2 SGS Business Overview
11.4.3 SGS Cytotoxicity Testing Introduction
11.4.4 SGS Revenue in Cytotoxicity Testing Business (2017-2022)
11.4.5 SGS Recent Developments
11.5 Emery Pharma
11.5.1 Emery Pharma Company Details
11.5.2 Emery Pharma Business Overview
11.5.3 Emery Pharma Cytotoxicity Testing Introduction
11.5.4 Emery Pharma Revenue in Cytotoxicity Testing Business (2017-2022)
11.5.5 Emery Pharma Recent Developments
11.6 Nelson Labs
11.6.1 Nelson Labs Company Details
11.6.2 Nelson Labs Business Overview
11.6.3 Nelson Labs Cytotoxicity Testing Introduction
11.6.4 Nelson Labs Revenue in Cytotoxicity Testing Business (2017-2022)
11.6.5 Nelson Labs Recent Developments
11.7 UFAG Laboratorien AG
11.7.1 UFAG Laboratorien AG Company Details
11.7.2 UFAG Laboratorien AG Business Overview
11.7.3 UFAG Laboratorien AG Cytotoxicity Testing Introduction
11.7.4 UFAG Laboratorien AG Revenue in Cytotoxicity Testing Business (2017-2022)
11.7.5 UFAG Laboratorien AG Recent Developments
11.8 Pacific BioLabs
11.8.1 Pacific BioLabs Company Details
11.8.2 Pacific BioLabs Business Overview
11.8.3 Pacific BioLabs Cytotoxicity Testing Introduction
11.8.4 Pacific BioLabs Revenue in Cytotoxicity Testing Business (2017-2022)
11.8.5 Pacific BioLabs Recent Developments
11.9 NorthEast BioLab
11.9.1 NorthEast BioLab Company Details
11.9.2 NorthEast BioLab Business Overview
11.9.3 NorthEast BioLab Cytotoxicity Testing Introduction
11.9.4 NorthEast BioLab Revenue in Cytotoxicity Testing Business (2017-2022)
11.9.5 NorthEast BioLab Recent Developments
11.10 Biosafe Ltd
11.10.1 Biosafe Ltd Company Details
11.10.2 Biosafe Ltd Business Overview
11.10.3 Biosafe Ltd Cytotoxicity Testing Introduction
11.10.4 Biosafe Ltd Revenue in Cytotoxicity Testing Business (2017-2022)
11.10.5 Biosafe Ltd Recent Developments
11.11 Creative Bioarray
11.11.1 Creative Bioarray Company Details
11.11.2 Creative Bioarray Business Overview
11.11.3 Creative Bioarray Cytotoxicity Testing Introduction
11.11.4 Creative Bioarray Revenue in Cytotoxicity Testing Business (2017-2022)
11.11.5 Creative Bioarray Recent Developments
11.12 Evercyte
11.12.1 Evercyte Company Details
11.12.2 Evercyte Business Overview
11.12.3 Evercyte Cytotoxicity Testing Introduction
11.12.4 Evercyte Revenue in Cytotoxicity Testing Business (2017-2022)
11.12.5 Evercyte Recent Developments
11.13 IONTOX
11.13.1 IONTOX Company Details
11.13.2 IONTOX Business Overview
11.13.3 IONTOX Cytotoxicity Testing Introduction
11.13.4 IONTOX Revenue in Cytotoxicity Testing Business (2017-2022)
11.13.5 IONTOX Recent Developments
11.14 Applied StemCell
11.14.1 Applied StemCell Company Details
11.14.2 Applied StemCell Business Overview
11.14.3 Applied StemCell Cytotoxicity Testing Introduction
11.14.4 Applied StemCell Revenue in Cytotoxicity Testing Business (2017-2022)
11.14.5 Applied StemCell Recent Developments
11.15 Xenometrix AG
11.15.1 Xenometrix AG Company Details
11.15.2 Xenometrix AG Business Overview
11.15.3 Xenometrix AG Cytotoxicity Testing Introduction
11.15.4 Xenometrix AG Revenue in Cytotoxicity Testing Business (2017-2022)
11.15.5 Xenometrix AG Recent Developments
11.16 TÜV SÜD
11.16.1 TÜV SÜD Company Details
11.16.2 TÜV SÜD Business Overview
11.16.3 TÜV SÜD Cytotoxicity Testing Introduction
11.16.4 TÜV SÜD Revenue in Cytotoxicity Testing Business (2017-2022)
11.16.5 TÜV SÜD Recent Developments
11.17 Medicilon
11.17.1 Medicilon Company Details
11.17.2 Medicilon Business Overview
11.17.3 Medicilon Cytotoxicity Testing Introduction
11.17.4 Medicilon Revenue in Cytotoxicity Testing Business (2017-2022)
11.17.5 Medicilon Recent Developments
11.18 Huatongwei
11.18.1 Huatongwei Company Details
11.18.2 Huatongwei Business Overview
11.18.3 Huatongwei Cytotoxicity Testing Introduction
11.18.4 Huatongwei Revenue in Cytotoxicity Testing Business (2017-2022)
11.18.5 Huatongwei Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
Table 1. Global Cytotoxicity Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Elution Testing Method
Table 3. Key Players of Agar Overlay Method
Table 4. Key Players of Direct Contact Method
Table 5. Key Players of MTT Assay Method
Table 6. Key Players of Others
Table 7. Global Cytotoxicity Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Cytotoxicity Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Cytotoxicity Testing Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Cytotoxicity Testing Market Share by Region (2017-2022)
Table 11. Global Cytotoxicity Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Cytotoxicity Testing Market Share by Region (2023-2028)
Table 13. Cytotoxicity Testing Market Trends
Table 14. Cytotoxicity Testing Market Drivers
Table 15. Cytotoxicity Testing Market Challenges
Table 16. Cytotoxicity Testing Market Restraints
Table 17. Global Cytotoxicity Testing Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Cytotoxicity Testing Revenue Share by Players (2017-2022)
Table 19. Global Top Cytotoxicity Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytotoxicity Testing as of 2021)
Table 20. Ranking of Global Top Cytotoxicity Testing Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Cytotoxicity Testing Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cytotoxicity Testing Product Solution and Service
Table 24. Date of Enter into Cytotoxicity Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cytotoxicity Testing Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Cytotoxicity Testing Revenue Market Share by Type (2017-2022)
Table 28. Global Cytotoxicity Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Cytotoxicity Testing Revenue Market Share by Type (2023-2028)
Table 30. Global Cytotoxicity Testing Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Cytotoxicity Testing Revenue Share by Application (2017-2022)
Table 32. Global Cytotoxicity Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Cytotoxicity Testing Revenue Share by Application (2023-2028)
Table 34. North America Cytotoxicity Testing Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Cytotoxicity Testing Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Cytotoxicity Testing Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Cytotoxicity Testing Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Cytotoxicity Testing Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Cytotoxicity Testing Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Cytotoxicity Testing Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Cytotoxicity Testing Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Cytotoxicity Testing Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Cytotoxicity Testing Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Cytotoxicity Testing Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Cytotoxicity Testing Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Cytotoxicity Testing Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Cytotoxicity Testing Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Cytotoxicity Testing Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Cytotoxicity Testing Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Cytotoxicity Testing Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Cytotoxicity Testing Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Cytotoxicity Testing Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Cytotoxicity Testing Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Cytotoxicity Testing Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Cytotoxicity Testing Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Cytotoxicity Testing Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Cytotoxicity Testing Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Cytotoxicity Testing Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Cytotoxicity Testing Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Cytotoxicity Testing Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Cytotoxicity Testing Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Cytotoxicity Testing Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Cytotoxicity Testing Market Size by Country (2023-2028) & (US$ Million)
Table 64. Sartorius Company Details
Table 65. Sartorius Business Overview
Table 66. Sartorius Cytotoxicity Testing Product
Table 67. Sartorius Revenue in Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 68. Sartorius Recent Developments
Table 69. UL Company Details
Table 70. UL Business Overview
Table 71. UL Cytotoxicity Testing Product
Table 72. UL Revenue in Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 73. UL Recent Developments
Table 74. Eurofins Company Details
Table 75. Eurofins Business Overview
Table 76. Eurofins Cytotoxicity Testing Product
Table 77. Eurofins Revenue in Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 78. Eurofins Recent Developments
Table 79. SGS Company Details
Table 80. SGS Business Overview
Table 81. SGS Cytotoxicity Testing Product
Table 82. SGS Revenue in Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 83. SGS Recent Developments
Table 84. Emery Pharma Company Details
Table 85. Emery Pharma Business Overview
Table 86. Emery Pharma Cytotoxicity Testing Product
Table 87. Emery Pharma Revenue in Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 88. Emery Pharma Recent Developments
Table 89. Nelson Labs Company Details
Table 90. Nelson Labs Business Overview
Table 91. Nelson Labs Cytotoxicity Testing Product
Table 92. Nelson Labs Revenue in Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 93. Nelson Labs Recent Developments
Table 94. UFAG Laboratorien AG Company Details
Table 95. UFAG Laboratorien AG Business Overview
Table 96. UFAG Laboratorien AG Cytotoxicity Testing Product
Table 97. UFAG Laboratorien AG Revenue in Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 98. UFAG Laboratorien AG Recent Developments
Table 99. Pacific BioLabs Company Details
Table 100. Pacific BioLabs Business Overview
Table 101. Pacific BioLabs Cytotoxicity Testing Product
Table 102. Pacific BioLabs Revenue in Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 103. Pacific BioLabs Recent Developments
Table 104. NorthEast BioLab Company Details
Table 105. NorthEast BioLab Business Overview
Table 106. NorthEast BioLab Cytotoxicity Testing Product
Table 107. NorthEast BioLab Revenue in Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 108. NorthEast BioLab Recent Developments
Table 109. Biosafe Ltd Company Details
Table 110. Biosafe Ltd Business Overview
Table 111. Biosafe Ltd Cytotoxicity Testing Product
Table 112. Biosafe Ltd Revenue in Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 113. Biosafe Ltd Recent Developments
Table 114. Creative Bioarray Company Details
Table 115. Creative Bioarray Business Overview
Table 116. Creative Bioarray Cytotoxicity Testing Product
Table 117. Creative Bioarray Revenue in Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 118. Creative Bioarray Recent Developments
Table 119. Evercyte Company Details
Table 120. Evercyte Business Overview
Table 121. Evercyte Cytotoxicity Testing Product
Table 122. Evercyte Revenue in Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 123. Evercyte Recent Developments
Table 124. IONTOX Company Details
Table 125. IONTOX Business Overview
Table 126. IONTOX Cytotoxicity Testing Product
Table 127. IONTOX Revenue in Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 128. IONTOX Recent Developments
Table 129. Applied StemCell Company Details
Table 130. Applied StemCell Business Overview
Table 131. Applied StemCell Cytotoxicity Testing Product
Table 132. Applied StemCell Revenue in Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 133. Applied StemCell Recent Developments
Table 134. Xenometrix AG Company Details
Table 135. Xenometrix AG Business Overview
Table 136. Xenometrix AG Cytotoxicity Testing Product
Table 137. Xenometrix AG Revenue in Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 138. Xenometrix AG Recent Developments
Table 139. TÜV SÜD Company Details
Table 140. TÜV SÜD Business Overview
Table 141. TÜV SÜD Cytotoxicity Testing Product
Table 142. TÜV SÜD Revenue in Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 143. TÜV SÜD Recent Developments
Table 144. Medicilon Company Details
Table 145. Medicilon Business Overview
Table 146. Medicilon Cytotoxicity Testing Product
Table 147. Medicilon Revenue in Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 148. Medicilon Recent Developments
Table 149. Huatongwei Company Details
Table 150. Huatongwei Business Overview
Table 151. Huatongwei Cytotoxicity Testing Product
Table 152. Huatongwei Revenue in Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 153. Huatongwei Recent Developments
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cytotoxicity Testing Market Share by Type: 2021 VS 2028
Figure 2. Elution Testing Method Features
Figure 3. Agar Overlay Method Features
Figure 4. Direct Contact Method Features
Figure 5. MTT Assay Method Features
Figure 6. Others Features
Figure 7. Global Cytotoxicity Testing Market Share by Application: 2021 VS 2028
Figure 8. Medical Device Case Studies
Figure 9. Medical Accessories Case Studies
Figure 10. Others Case Studies
Figure 11. Cytotoxicity Testing Report Years Considered
Figure 12. Global Cytotoxicity Testing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Cytotoxicity Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Cytotoxicity Testing Market Share by Region: 2021 VS 2028
Figure 15. Global Cytotoxicity Testing Market Share by Players in 2021
Figure 16. Global Top Cytotoxicity Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytotoxicity Testing as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Cytotoxicity Testing Revenue in 2021
Figure 18. North America Cytotoxicity Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Cytotoxicity Testing Market Size Market Share by Type (2017-2028)
Figure 20. North America Cytotoxicity Testing Market Size Market Share by Application (2017-2028)
Figure 21. North America Cytotoxicity Testing Market Size Share by Country (2017-2028)
Figure 22. United States Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Cytotoxicity Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Cytotoxicity Testing Market Size Market Share by Type (2017-2028)
Figure 26. Europe Cytotoxicity Testing Market Size Market Share by Application (2017-2028)
Figure 27. Europe Cytotoxicity Testing Market Size Share by Country (2017-2028)
Figure 28. Germany Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Cytotoxicity Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Cytotoxicity Testing Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Cytotoxicity Testing Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Cytotoxicity Testing Market Size Share by Region (2017-2028)
Figure 38. China Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Latin America Cytotoxicity Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Cytotoxicity Testing Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Cytotoxicity Testing Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Cytotoxicity Testing Market Size Share by Country (2017-2028)
Figure 48. Mexico Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Cytotoxicity Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Cytotoxicity Testing Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Cytotoxicity Testing Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Cytotoxicity Testing Market Size Share by Country (2017-2028)
Figure 54. Turkey Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Sartorius Revenue Growth Rate in Cytotoxicity Testing Business (2017-2022)
Figure 58. UL Revenue Growth Rate in Cytotoxicity Testing Business (2017-2022)
Figure 59. Eurofins Revenue Growth Rate in Cytotoxicity Testing Business (2017-2022)
Figure 60. SGS Revenue Growth Rate in Cytotoxicity Testing Business (2017-2022)
Figure 61. Emery Pharma Revenue Growth Rate in Cytotoxicity Testing Business (2017-2022)
Figure 62. Nelson Labs Revenue Growth Rate in Cytotoxicity Testing Business (2017-2022)
Figure 63. UFAG Laboratorien AG Revenue Growth Rate in Cytotoxicity Testing Business (2017-2022)
Figure 64. Pacific BioLabs Revenue Growth Rate in Cytotoxicity Testing Business (2017-2022)
Figure 65. NorthEast BioLab Revenue Growth Rate in Cytotoxicity Testing Business (2017-2022)
Figure 66. Biosafe Ltd Revenue Growth Rate in Cytotoxicity Testing Business (2017-2022)
Figure 67. Creative Bioarray Revenue Growth Rate in Cytotoxicity Testing Business (2017-2022)
Figure 68. Evercyte Revenue Growth Rate in Cytotoxicity Testing Business (2017-2022)
Figure 69. IONTOX Revenue Growth Rate in Cytotoxicity Testing Business (2017-2022)
Figure 70. Applied StemCell Revenue Growth Rate in Cytotoxicity Testing Business (2017-2022)
Figure 71. Xenometrix AG Revenue Growth Rate in Cytotoxicity Testing Business (2017-2022)
Figure 72. TÜV SÜD Revenue Growth Rate in Cytotoxicity Testing Business (2017-2022)
Figure 73. Medicilon Revenue Growth Rate in Cytotoxicity Testing Business (2017-2022)
Figure 74. Huatongwei Revenue Growth Rate in Cytotoxicity Testing Business (2017-2022)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed